The hydroxyl radical (OH') scavenger dimethyl sulfoxide (DMSO) was found to dose-dependently inhibit interleukin 8 (IL-8) production in LPS-stimulated human whole blood. At a concentration of 1% (vol/ vol), DMSO blocked IL-8 release by 90% in the presence of 1 ,ug/ml LPS at a 24-h time point, but did not affect cell viability or reduce the production of tumor necrosis factor (TNF), interleukin 6, or interleukin-1fi ). DMSO was found to directly inhibit IL-8 expression at the level of transcription. Furthermore, this effect was not LPS-specific, in that IL-8 production was reduced by DMSO to a similar extent upon stimulation of blood with phytohemagglutinin, aggregated immune complexes, TNF, or IL-1ft.
Introduction
Interleukin 8 (IL-8) is a member ofa recently described family of low molecular weight cytokines. This neutrophil chemoattractant/activator is produced by a wide variety of cell types, including monocytes, endothelial cells, and fibroblasts ( 1, 2) . Its production is elicited by inflammatory stimuli such as lipopolysaccharide (LPS) and phytohemagglutinin (PHA), as well as by proinflammatory cytokines, specifically tumor necrosis factor (TNF)' and interleukin I # (IL-I l) ( 1, 2) . Although the presence of IL-8 has been detected in several disease states (3) (4) (5) (6) (7) (8) (9) (10) , it is presently unclear what role IL-8 plays in attracting neutrophils to tissue sites in vivo. This issue is of considerable importance as newly recruited neutrophils are capable of mediating extensive tissue damage. This has been particularly well established in experimental models of ischemia/reperfusion injury (1 1-15) . In such models, reactive oxygen intermediates (ROI), produced upon reoxygenation of ischemic tissue, appear to be a critical component ofthe injury process. They not only directly contribute to the tissue damage (16) (17) (18) (19) , but also initiate neutrophil recruitment by causing the production of various neutrophil chemotactic factors (20) (21) (22) . These observations have led us to investigate whether ROI may mediate IL-8 production.
Human whole blood was used in these studies as an ex vivo model of local cytokine production (23) (24) (25) . By retaining the integrity ofthis tissue system, the leukocytes are maintained in their physiologic environment, cellular interactions are preserved, and potential artifacts resulting from adherence or lengthy isolation procedures are avoided. This model has been extensively used in our laboratory (23) (24) (25) , as well as by multiple other investigators (26) (27) (28) (29) (30) . In the present report, we demonstrate that oxygen radical scavengers dramatically inhibit production of IL-8 in LPS-stimulated human whole blood.
Methods
Reagents. LPS (Escherichia coli 01 1 1 :B4), DMSO Experimental design. Experiments were performed essentially as described (24) . Briefly, blood from normal male volunteers was drawn into heparinized syringes (20 U heparin/ml), and l-ml aliquots were placed in sterile 1.5-ml centrifuge tubes. As required, ROI scavengers and LPS (using a 200 ug/ml stock solution) were added to the aliquots.
The blood was then placed on a rotator and incubated at 370C in a humidified atmosphere containing 5% CO2. At the designated time point, samples were removed from the incubator and immediately cen-trifuged at 600 g for 5 min. The plasma was then removed, diluted 1:5 with RPMI 1640 media (Gibco Laboratories, Grand Island, NY) containing 1% fetal bovine serum (FBS) , and stored at -20'C for later cytokine analysis. For some samples, the buffy coat was removed from the top of the packed red blood cells and contaminating red cells were lysed with 0.82% NH4Cl. The white blood cells were pelleted by centrifugation and dissolved in 0.3 ml of an RNA extraction buffer (25 mM Tris, pH 8.0, 4.2 M guanidine isothiocyanate, 0.5% N-laurosarcosine, and 0.1 M 2-mercaptoethanol). The samples were stored at -70'C for later processing.
White blood cell (WBC) viability. Viability studies were performed as described (25) . Aliquots of blood left unstimulated or stimulated with LPS in the presence of increasing concentrations of DMSO were incubated as described above for 24 h. The buffy coat was then isolated, subjected to NH4Cl lysis twice to completely clear red blood cell contamination, and resuspended in 1 ml RPMI containing 1% FBS, 100 U/ml penicillin, 100 Ag/ml streptomycin, 1 mM L-glutamine, 25 IL-8 assay. The plasma IL-8 concentrations were determined by ELISA (36) using native and biotinylated rabbit polyclonal anti-IL-8 antibody as the capture and secondary antibodies, respectively. Horseradish peroxidase-conjugated avidin (Dako, Corp., Carpinteria, CA) and o-phenylenediamine tablets (Dako Corp.) were used for color development. The lower limity of sensitivity of the assay was typically < 80 pg/ml. Connective tissue activating peptide III, platelet factor 4, neutrophil activating peptide 2, and melanoma growth stimulating activity were not detectable in this assay. The presence of DMSO had no effect on the ability of this ELISA to reliably detect IL-8.
IL-JIf assay. Plasma IL-l, levels were measured using an ELISA as described (37) . ILB1-H6 and biotinylated ILB1-H67 were the monoclonal antibodies used as capture and secondary antibodies, respectively. The color development reagents were horseradish peroxidaseconjugated streptavidin (Zymed, South San Francisco, CA) and ophenylenediamine tablets (Zymed). This assay was typically sensitive to < 50 pg/ml using KinetiCalc software (Bio-Tek Instruments, Inc.).
Northern blot analysis. Total RNA was extracted from the WBC pellets and mRNA levels were assessed by Northern blot analysis using our previously described techniques (24) . The blots were hybridized with the 32P-5' end-labeled 30-mer oligonucleotide for IL-8 5'-GTT GGC-GCA-GTG-TGG-TCC-ACT-CTC-AAT-CAC-3' (38) 
Results
Initial studies to evaluate the role of reactive oxygen intermediates in inducing IL-8 expression were performed using DMSO, a known OH" scavenger (40) . DMSO was chosen because it has low toxicity, it has been found to have beneficial effects in a wide range ofdisease models, and it possesses chemical properties which allow it to readily penetrate cell membranes (41, 42 The effect of 1% DMSO on the time course of IL-8 production was also evaluated (Fig. 1 B) . In the presence ofLPS alone (1 Mug/ml), plasma IL-8 levels were observed to increase in a biphasic pattern. This extremely reproducible profile of release has been documented in our laboratory (23, 24) . Previous studies have shown that the secondary phase of IL-8 production occurring between 12 and 24 h is completely inhibitable by the addition of neutralizing anti-TNF and anti-IL-1 antibodies (24) . The early phase ofIL-8 production (2-12 h) is unaffected by the presence of these antibodies, suggesting it is an LPS-mediated response. Interestingly, DMSO significantly reduced IL-8 production over the entire time course, indicating that its mechanism of inhibition was quite different from that of the anti-cytokine antibodies. DMSO treatment suppressed LPSdependent IL-8 production by 39 .6±9.5% and 90.7±1.0% (mean±SEM, n = 5) at 6 and 24 h, respectively.
To determine whether the DMSO-induced reduction in LPS-dependent IL-8 production was occurring at the level of transcription or translation, Northern blot analysis was performed on RNA extracted from the buffy coats of blood samples incubated for 3 h with LPS (1 Mg/ml) in the presence and absence of 1% DMSO. A significant reduction in LPS-stimulated IL-8 mRNA levels was observed upon incubation with DMSO (Fig. 2) protein synthesis inhibitor cycloheximide (CHX). Blood samples were incubated with LPS + CHX (5 ,ug/ml) or LPS + DMSO + CHX. IL-8 mRNA was similarly suppressed by DMSO under these conditions indicating that DMSO has a direct inhibitory effect. As previously noted (1), superinduction of IL-8 mRNA was evident in the presence of cycloheximide.
The effect of DMSO on the production of other cytokines was also evaluated. The results shown in Fig. 3 are representative of more than four experiments and demonstrate that the inhibitory effect of DMSO was highly specific for IL-8. The presence of 1% DMSO had no effect on the release of TNF.
IL-I# and IL-6 concentrations, however, were elevated in the presence of DMSO. This trend did not reach statistical significance in the case of IL-1A, but IL-6 levels were significantly increased at nearly every time point (P < 0.05, Student's t test).
To determine whether this profound reduction in IL-8 release by DMSO is a generalized phenomenon or specific to an LPS stimulus, the ability ofDMSO to block IL-8 production in the presence of other stimuli was addressed. The additional agents included PHA, 10 gg/ml; endotoxin-free aggregated immune complexes (IC), 250 Ag/ml; TNF, 370 ng/ml; and IL-1/3, 100 ng/ml (Table I) . Each of these stimuli elicited production of substantial concentrations of IL-8 (10 ng/ml or greater). Addition of DMSO reduced plasma IL-8 levels by 86-97% for all stimuli.
In all of the preceding studies, DMSO has been used as a prototypical scavenger ofOH'. Further studies were performed to determine whether other compounds classically used as ROI scavengers were capable of mediating a similar effect (Table   II) . DMTU, reported to be a H202 scavenger by some investigators (43) and a OH' scavenger by others (44) , equaled or exceeded the ability of DMSO to reduce plasma IL-8 levels.
TU, a scavenger of both OH' and H202 (45) , also profoundly inhibited IL-8 release, while mannitol and ethanol were typically somewhat less efficacious (40) . Other agents, however, were ineffective in reducing IL-8 production. These include catalase and SOD, enzymes which metabolize H202 and superoxide anion (O -), respectively; deferoxamine, an iron chelator purported to reduce OH' production from°2 and H202 via the iron-catalyzed Fenton reaction; and allopurinol, a xanthine oxidase inhibitor. Additional studies demonstrated that oxypurinol also had no effect on the production of IL-8 (data not shown). The results in Table II are representative of at least three experiments with five blood donors each. Use of the above compounds at the stated concentrations had no effect on the viability of the white blood cells (data not shown).
These studies have established that ROI scavengers are capable of inhibiting IL-8 production. We next wished to determine whether exposure of whole blood to an oxidant stress would induce IL-8 release. Dose response studies were therefore performed in which H202 was directly added to blood in concentrations ranging from 0.019% to 0.15%. Cell viability was not significantly affected by the addition of 0.15% H202 (data not shown). Results representing a compilation of two studies are shown in Fig. 4 . H202 dose-dependently stimulated IL-8 release, with the IL-8 concentrations measured in the presence of 0.15% H202 being significantly higher than those in control samples or in samples incubated with 0.019%, 0.038%, or 0.075% H202 (P < 0.05, Student-Newman-Keuls test). Importantly, addition of 1% DMSO to blood stimulated with 0.15% H202 caused a 90.1±5.0% reduction in plasma IL-8 levels (17.6±8.3 vs. 0.3±0.05 ng/ml IL-8 for 0.15% H202 alone and H202 combined with 1% DMSO, respectively [mean±SEM, n = 9]; P < 0.05, Student-Newman-Keuls test). Discussion ROI can be generated by several potential pathways. Sources of°2 include the mitochondrial electron transport chain and enzymatic generation by xanthine oxidase and NADPH-oxidase (46) (47) (48) . In a spontaneous or SOD-catalyzed reaction,°2 is reduced to H202. The resulting H202 can then be detoxified by catalase or glutathione peroxidase to yield H20, or may alternatively react with reduced iron to form highly cytotoxic OH' (46) (47) (48) . Low molecular weight, membrane permeable scavengers such as DMSO, DMTU, and TU were observed in this study to be the most effective agents in reducing IL-8 production. The failure of SOD and catalase to reduce IL-8 production may reflect the inability of these charged, high molecular weight proteins to cross cell membranes (49) (50) (51) . In addition, the lack of effect of allopurinol suggests that xanthine oxidase does not substantially contribute to ROI production in this model. Lastly, although the ability of DMSO to reduce IL-8 release suggests the involvement ofOH', deferoxamine had no inhibitory effect and actually increased IL-8 production in some instances (Table II) . The failure of deferoxamine to reduce IL-8 may potentially be explained by the limited cellular uptake of deferoxamine and the high iron binding capacity of plasma which limits the availability of free iron (52 tactic factors. These include a chloroform extractable, albumin-associated factor generated by treating plasma with O2- (20) ; an arachidonic acid metabolite produced upon incubation with xanthine oxidase (21); and a C.,%-like chemoattractant generated by H202 (22) . Such factors may constitute an important amplifying mechanism in the initiation of reperfusion injury leading to the recruitment of neutrophils which further augment tissue injury by the release of proteases and NADPH-oxidase generated oxygen radicals (53 . Although emphasis has been placed on the relevance of ROI to ischemia/reperfusion injury, oxygen radicals may play a significant role in many other disease processes such as arthritis, atherosclerosis, and adult respiratory distress syndrome (52) . Whereas LPS and the other soluble inflammatory mediators used in these studies cannot be directly compared to the conditions accompanying ischemia/reperfusion, all stimuli employed in these studies have been demonstrated to result in the formation of oxygen radicals. This has been particularly well characterized for phagocytic cells (56-61 ) but appears to be a more generalized phenomenon. Superoxide production has been observed to occur in endothelial cells in response to IL-1I and interferon-y (62), in fibroblasts in response to IL-la and TNF (63) , in chondrocytes and synovial cells in response to TNF (64).
DMSO has been used clinically as an anti-inflammatory agent in arthritis and other disease states (41, 42) . The present studies suggest that inhibition of IL-8 production may, in part, have contributed to its beneficial effects. Additional anti-inflammatory properties of DMSO that have been recently discovered include its ability to prevent adhesion ofneutrophils to endothelium (65), to scavenge hypochlorous anion (66) , and possibly to reduce NADPH-oxidase activity (66) . Pretreatment with DMTU reduced the chemotatic activity in the plasma of sheep injected with endotoxin, demonstrating the in vivo efficacy of the membrane permeable scavengers (67) . Of the cytokines measured in this study, the inhibitory effect of DMSO was highly specific for IL-8. While TNF levels were unaffected by DMSO, IL-lIl release tended to be elevated and Oxygen Radical Scavengers Selectively Inhibit Interleukin 8 Production 2127 * H202 ALONE V H202 + 1% DMSO IL-6 concentrations were significantly increased. Although the importance of these changes is unclear, the elevation in IL-6 levels may potentially represent a protective effect induced by DMSO. IL-6 is known to enhance host immune functions and induce the acute phase response.
In conclusion, these studies provide convincing evidence that endogenously produced ROI directly induce the transcription and translation of IL-8. The results suggest that the ability of oxygen radical scavengers to inhibit ischemia/reperfusion injury and inflammation may be, in part, secondary to a decrease in local production of IL-8 and a subsequent reduction in elicitation of neutrophils.
